PA21

AssetSmall molecule

Phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease

Stage
Phase 2
Modality
Small molecule
Target
Not known
Indications
1
Trials
77
Developers
1

Indications

1
  • Targets and what it contains1
  • Owner and partners1
  • Trials77
  • Evidence for its targets1
  • Competitors8
  • Signals7

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Updated 7 Oct 2026 · 2 sources

Assets